1. Home
  2. Blog
  3. Healthcare Provider
  4. Myriad Genetics achieves HITRUST certified status for GeneSight

Myriad Genetics achieves HITRUST certified status for GeneSight

Myriad Genetics achieves HITRUST certified status for GeneSight

This material has been reviewed for accuracy by: Renee Albers, PhD

Information security and privacy is a critical part of the healthcare landscape for clinicians, patients, insurance companies, third party labs and beyond as they increasingly share private, protected information digitally. That’s why the Myriad Genetics team is proud to announce that they have achieved HITRUST Certified status for the GeneSight product, solidifying Myriad as a trusted partner for our providers, payors, and patients.

“We take the privacy of our patients and the customers we serve very seriously,” said Paul Diaz, president and CEO, Myriad Genetics. “Myriad is committed to the highest standards for data protection by ensuring all systems and processes in place are meeting complex compliance and security requirements. We are proud to showcase that commitment with the HITRUST Risk-based, 2-year Certification for our GeneSight product.”

Since it was founded in 2007, the HITRUST has championed programs that safeguard sensitive information and manage information risk through collaboration with privacy, information security and risk management leaders. HITRUST CSF will ensure that your organization is staying up-to-date with the latest security and privacy standards to ensure your sensitive data is effectively and efficiently safeguarded.

“With our recent HITRUST certification, Myriad continues to benchmark our passion and integrity for security, information protection, and technical innovation around a compliant framework that ensures one of our most valuable commodities – our client’s privacy,” said Chris Williamson, chief information officer, Myriad Genetics.

The HITRUST Risk-based, 2-year (r2) Certified status demonstrates that Myriad’s GeneSight product and ordering platform has met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places Myriad Genetics in an elite group of organizations worldwide that have earned this certification.

“The privacy landscape is changing daily. We want our customers to know that we take their privacy seriously,” said Clivetty Martinez, chief compliance officer, Myriad Genetics. This HITRUST certification demonstrates the highest standards of information risk management, security and compliance.”

In addition to the HITRUST certification, the GeneSight product is also:

  • Fully compliant with HIPAA, HITECH and GINA regulations
  • CLIA and CAP accredited
  • NY State Department of Health approved

You can find a full list of state and federal licenses and certifications on the GeneSight.com website: https://genesight.com/quality-and-compliance/

Our articles are for informational purposes only and are reviewed by our Medical Information team, which includes PharmDs, MDs, and PhDs. Do not make any changes to your current medications or dosing without consulting your healthcare provider.

The GeneSight test must be ordered by and used only in consultation with a healthcare provider who can prescribe medications. As with all genetic tests, the GeneSight test results have limitations and do not constitute medical advice. The test results are designed to be just one part of a larger, complete patient assessment, which would include proper diagnosis and consideration of your medical history, other medications you may be taking, your family history, and other factors.

If you are a healthcare provider and interested in learning more about the GeneSight test, please contact us at 855.891.9415. If you are a patient, please talk with your doctor to see if the GeneSight test may be helpful.

Published: February 25, 2022